Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of ciprofol + butorphanol for monitored anesthesia in minimally invasive breast circumcision
ChiCTR2300078703Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Dec 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol and butorphanol in breast neoplasia, sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoint: Bispectral Index (BIS). Planned start Dec 2023; status: not yet recruiting.
02
Drugs
ciprofolbutorphanol
03
Conditions
breast neoplasia
Beyond the preview
Go deeper on ChiCTR2300078703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078703.